Average Co-Inventor Count = 6.79
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (20 from 174 patents)
2. Pfizer Corporation (10 from 4,455 patents)
3. Pfizer Products Inc. (47 patents)
30 patents:
1. 10709709 - Substituted carbonucleoside derivatives useful as anticancer agents
2. 10428104 - Substituted nucleoside derivatives useful as anticancer agents
3. 10246433 - Aryl and heteroaryl fused lactams
4. 10220037 - Substituted carbonucleoside derivatives useful as anticancer agents
5. 9040515 - Aryl and heteroaryl fused lactams
6. 8268835 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
7. 7868026 - Therapeutic compounds
8. 7622605 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
9. 7473790 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
10. 7179918 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11. 7151105 - Inhibitors of Hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12. 7148226 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
13. 7115658 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase
14. 6953858 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
15. 6693199 - Method of making HIV protease inhibitors